blue digital circular waveforms

Webinars

Oct 14, 2023

Symposium, JFR21 Intelligence artificielle pour le cancer du sein : révolution actuelle et future pour un meilleur dépistage

Samedi 8 octobre Le Pr Bruno Boyer, CIMI, Paris explique le rôle et l’impact clinique de l’utilisation des solutions d’intelligence artificielle d’iCAD en pratique quotidienne à travers des exemples de cas cliniques et le Pr Corinne Balleyguier de l’Institut Gustave Roussy présente les résultats d’études cliniques montrant les performances des…

Jul 20, 2023

ProFound Insights, ProFound Impact: How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most

Thursday, July 20, 2023 While radiologists are trained experts in detecting breast cancer, certain types of tumors are still difficult to detect due to their elusive nature. Join us for a compelling discussion with Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic, who will share how iCAD’s…

May 24, 2023

ProFound Insights, ProFound Impact: Elevating Accuracy Across the Board at Boca Raton Regional Hospital

Wednesday, May 24, 2023 Kathy Schilling, MD, Medical Director, Boca Raton Regional Hospital, recently presented data at the ECR demonstrating how ProFound AI helped nine dedicated breast radiologists find 23% more cancers, without increasing the rate of recalls. Join us as we sit down with Dr. Schilling to discuss what…

Apr 1, 2023

Workshop iCAD: Impact des solutions d’intelligence artificielle ProFound AI® en routine clinique pour la détection du cancer du sein sur mammographies et tomosynthèses

Avril 2023 Dr Julia Arfi Rouche, Radiologue à Imagerie 114 à Paris – Retour d’expérience sur l’intégration des solutions ProFound AI pour la détection du cancer du sein en routine clinque illustré par des cas cliniques rencontrés au cours des derniers mois.

Dec 14, 2022

ProFound Insights, ProFound Impact: Leveraging ProFound AI to Enhance Patient Care at Solis Mammography

Wednesday, December 14, 2022 Solis Mammography, the largest independent provider of mammography and breast health services in the United States, was an early adopter of iCAD’s suite of breast AI solutions, integrating the technology into its early detection screening platform in the spring of 2021. Hear from Chirag Parghi, MD,…

Jul 18, 2022

ProFound Insights, ProFound Impact: ProFound AI Risk in the Real-World

Monday, July 18, 2022 Back by popular demand! Leading experts, Dr. Mark Traill and Dr. Axel Gräwingholt, returned to our virtual stage for an encore “ProFound Insights, ProFound Impact” event and clinical case study review. Join us as we take a deeper dive into a range of real-world cases and…

Jun 21, 2022

ProFound Insights, ProFound Impact: Risk Assessment Reimagined

Tuesday, June 21, 2022 Discover the power of ProFound AI® Risk, the latest addition to iCAD’s breast AI suite and the world’s first clinical decision support tool that provides an accurate, short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Watch as…

May 10, 2022

ProFound Insights, ProFound Impact: Why ProFound AI Prevailed as the Premier AI Solution in a Competitive Trial at Wake Radiology

Tuesday, May 10, 2022 With 14 imaging locations in the Raleigh-Durham metropolitan area, Wake Radiology offers a wide array of imaging exams in the outpatient setting, including both screening and diagnostic mammography. But when the facility upgraded to 3D mammography, the organization soon realized that the substantial increase in the…

Apr 27, 2022

ProFound Insights, ProFound Impact: Why Kettering Health Traded out Previous AI Software for ProFound AI® Enterprise-Wide

Wednesday, April 27, 2022 Experience a compelling conversation featuring leading experts in breast imaging and hospital administration from Kettering Health, a leading enterprise breast care provider with 14 breast centers across southwest Ohio, and discover how iCAD’s world-class AI breast health solutions offer a trifecta of unrivaled, clinically proven benefits…

Apr 19, 2022

Solutions d’intelligence artificielle pour la détection du cancer du sein et l’évaluation du risque

Mardi 19 avril 2022 Près de 5 millions de mammographies sont effectuées en France chaque année. Les solutions d’IA pour la détection du cancer du sein sont devenues une aide précieuse au quotidien pour les radiologues. Panorama sur la mise en place l’IA pour la détection du cancer du sein…